NCT03491176View on ClinicalTrials.gov

Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

May 18, 2017

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Cutaneous Squamous Cell Carcinoma of the Head and NeckHealthy SubjectHead and Neck Cancer
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI scan

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT03491176 - Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer | Biotech Hunter | Biotech Hunter